Clinical and bacteriologic epidemiology of extended-spectrum β- lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit

Clinical Infectious Diseases

Volumn 27, Issue 4, 1998, Pages 834-844

  Decré, Dominique ^a,b   Gachot, Bertrand ^a   Lucet, Jean Christophe ^a   Arlet, Guillaume ^a   Bergogne Bérézin, Eugénie ^a   Régnier, Bernard ^a  

^a BICHAT HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIAL ENZYME; BETA LACTAMASE;

ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DNA POLYMORPHISM; ENTEROBACTER INFECTION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; NONHUMAN; PLASMID; PRIORITY JOURNAL; STRAIN DIFFERENCE; URINARY TRACT INFECTION;

EID: 2442743102     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514938     Document Type: Article

References (60)

1. Arlet G, Sanson-le-Pors MJ, Rouveau M, et al. Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 β-lactamase. Eur J Clin Microbiol 1990; 9:179-84.
2. Bingen E, Desjardin P, Arlet G, et al. Molecular epidemiology of plasmid spread among extended broad-spectrum β-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital. J Clin Microbiol 1993; 31:179-84.
3. Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval J. Transferable enzymatic resistance to third-generation cephalosporins during a nosocomial outbreak of multi-resistant Klebsiella pneumoniae. Lancet 1987; 2:302-6.
4. Buré A, Legrand P, Arlet G, Jarlier V, Paul G, Philippon A. Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable resistance to third-generation cephalosporins and aztreonam. Eur J Clin Microbiol Infect Dis 1988; 7:780-2.
5. De Champs C, Sirot D, Chanal C, Poupart MC, Dumas MP, Sirot J. Concomitant dissemination of three extended-spectrum β-lactamases among different Enterobacteriaceae isolated in a French hospital. J Antimicrob Chemother 1991; 27:441-7.
6. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended-broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10:867-78.
7. Philippon A, Ben Redjeb S, Fournier G, Ben Hassen A. Epidemiology of extended-spectrum β-lactamases. Infection 1989; 17:347-51.
8. Sirot D, Sirot J, Morand A, et al. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae. Identification of CTX-1, a novel β-lactamase. J Antimicrob Chemother 1987; 20: 323-34.
9. Sirot J, Chanal C, Petit A, Sirot D, Labia R, Gerbaud G. Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated β-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. Rev Infect Dis 1988; 10:850-9.
10. Sirot D, Goldstein F, Soussy CJ, et al. Resistance to cefotaxime and other β-lactams in members of the Enterobacteriaceae: a 3-year survey in France. Antimicrob Agents Chemother 1992; 36:1677-81.
11. Sirot D. Extended-spectrum β-lactamases. J Antimicrob Chemother 1995; 36(suppl A): 19-34.
12. Jacoby GA, Medeiros AA. More extended-spectrum β-lactamases. Antimicrob Agents Chemother 1991; 35:1697-704.
13. Philippon A, Labia R, Jacoby GA. Extended-spectrum β-lactamases. Antimicrob Agents Chemother 1989; 33:1131-6.
14. Philippon A, Arlet G, Lagrange PH. Origin and impact of plasmid-mediated extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis 1994; 13(suppl 1):S17-9.
15. Jacoby GA, Sutton L. Properties of plasmids responsible for production of extended-spectrum β-lactamases. Antimicrob Agents Chemother 1991; 35:164-9.
16. Petit A, Gerbaud G, Sirot D, Courvalin P, Sirot J. Molecular epidemiology of TEM-3 (CTX-1) β-lactamase. Antimicrob Agents Chemother 1990; 34:219-24.
17. Goldstein FW, Péan Y, Rosato A, Gertner J, Gutmann L, the Vigil'Roc Study Group. Characterisation of ceftriaxone-resistant Enterobacteriaceae: a multicentre study in 26 French hospitals. J Antimicrob Chemother 1993; 32:595-603.
18. Hammani A, Arlet G, Ben Redjeb S, et al. Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit caused by multiply drug resistant Salmonella wien producing SHV-2 β-lactamase. Eur J Clin Microbiol Infect Dis 1991; 10:641-6.
19. Mariotte S, Nordmann P, Nicolas MH. Extended-spectrum β-lactamase in Proteus mirabilis. J Antimicrob Chemother 1994; 33:925-35.
20. Bauerfeind A, Rosenthal E, Eberlein E, Holley M, Schweighart S. Spread of Klebsiella pneumoniae producing SHV-5 β-lactamase among hospitalized patients. Infection 1993; 21:18-22.
21. Johnson AP, Weinbren MJ, Ayling-Smith B, Du Bois SGB, George RC. Outbreak of infection in two UK hospitals caused by a strain of Klebsiella pneumoniae resistant to cefotaxime and ceftazidime. J Hosp Infect 1992; 20:97-103.
22. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella pneumoniae resistant to late-generation cephalosporins. Ann Intern Med 1993; 119:353-8.
23. Naumovski L, Quinn JP, Miyashiro D, et al. Outbreak of ceftazidime resistance due to a novel extended-spectrum β-lactamase in isolates of cancer patients. Antimicrob Agents Chemother 1992; 36:1991-6.
24. Rice LB, Willey SH, Papanicolaou GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic care facility. Antimicrob Agents Chemother 1990; 34:2193-9.
25. De Champ C, Sauvant MP, Chanal CM, et al. Prospective survey of colonization and infections caused by expanded-spectrum β-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit. J Clin Microbiol 1989; 12:2887-90.
26. Casewell MW, Phillips I. Hands as a route of transmission for Klebsiella species. BMJ 1977;2:1315-7.
27. Chanal CM, Sirot DL, Petit A, et al. Multiplicity of TEM-derived β-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationship between the responsible plasmids. Antimicrob Agents Chemother 1989; 33:1915-20.
28. Kitzis MD, Billot-Klein D, Goldstein FW, et al. Dissemination of the novel plasmid-mediated β-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by β-lactamase inhibitors. Antimicrob Agents Chemother 1988; 32:9-14.
29. Lucet JC, Chevret S, Decré D, et al. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 1996; 22:430-6.
30. Legrand P, Fournier G, Buré A, et al. Detection and distribution of extended-broad-spectrum β-lactamases in Enterobacteriaceae in four French hospitals. Eur J Clin Microbiol Infect Dis 1989; 8:527-9.
31. Swenson JM, Hinler JA, Peterson LR. Special tests for detecting antibacterial resistance. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995:1356-67.
32. Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8:557-84.
33. Acar J, Chardon P, Choutet P, et al. Comité Français de l'Antibiogramme de la Société Française de Microbiologie. Communiqué 1996. Pathol Biol (Paris) 1996;44(8):I-VIII.
34. Matthew M, Harris AM, Marshall MG, Ross GW. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 1975; 88:169-78.
35. Kado CI, Liu ST. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 1981; 145:1365-73.
36. Smith CL, Cantor CR. Purification, specific fragmentation, and separation of large DNA molecules. Methods Enzymol 1987; 155:449-67.
37. Tenover F, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-9.
38. Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genome. Nucleic Acid Res 1991; 19:6823-31.
39. Liu PYF, Gur D, Hall LMC, Livermore DM. Survey of the prevalence of β-lactamases amongst 1000 Gram-negative bacilli isolated consecutively at the Royal London Hospital. J Antimicrob Chemother 1992; 30:429-47.
40. Brun-Buisson C, Legrand P, Rauss F, et al. Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Ann Intern Med 1989; 110:873-81.
41. Andremont A, Sancho-Garnier H, Tancrede C. Epidemiology of intestinal colonization by members of the family Enterobacteriaceae highly resistant to erythromycin in hematology-oncology unit. Antimicrob Agents Chemother 1986; 29:1104-7.
42. Andremont A, Gerbaud G, Courvalin P. Plasmid-mediated high-level resistance to erythromycin in Escherichia coli. Antimicrob Agents Chemother 1986; 29:515-8.
43. De Champs C, Guelon DP, Garnier RM, et al. Selective digestive decontamination by erythromycin-base in a polyvalent intensive care unit. Intensive Care Medicine 1993; 19:191-6.
44. Lucet JC, Fichelle A, Decré D, et al. Control of a prolonged outbreak of extended-spectrum β-lactamase-producing Enterobacteriaceae in a university hospital [abstract no. J108]. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1996:238.
45. Arlet G, Rouveau M, Casin I, Bouvet PJM, Lagrange PH, Philippon A. Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 β-lactamase and which were isolated in 14 French hospitals. J Clin Microbiol 1994; 32:2553-8.
46. Gouby A. Neuwirth C, Bourg G, et al. Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. J Clin Microbiol 1994;32:301-5.
47. Gori A, Espinasse F, Deplano A, Nonhoff C, Nicolas MH, Struelens M. Comparison of pulsed-field gel electrophoresis and randomly amplified DNA polymorphism analysis for typing extended-spectrum-β-lactamase-producing Klebsiella pneumoniae. J Clin Microbiol 1996; 34:2448-53.
48. Eisen D, Russel EG, Tymms M, Roper EJ, Grayson ML, Tunidge J. Random amplified polymorphic DNA and plasmid analysis used in investigation of an outbreak of multiresistant Klebsiella pneumoniae. J Clin Microbiol 1995; 33:713-7.
49. Thompson W, Romance L, Bialkowska-Hobrazanska H, Rennie RP, Ashton F, Nicolle LE. Klebsiella pneumoniae infection on a rehabilitation unit: comparison of epidemiologic typing methods. Infect Control Hosp Epidemiol 1993; 14:203-10.
50. Wallia S, Madhavan T, Reuman P, Tewari R, Duckwork D. Plasmid profiles and klebocin in epidemiologic studies of infections by Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis 1988; 7:279-84.
51. Mayer L. Use of plasmid profile in epidemiologic surveillance of disease outbreaks and in tracing the transmission of antibiotic resistance. Clin Microbiol Rev 1988; 1:228-43.
52. Goering RV. Molecular epidemiology of nosocomial infection: analysis of chromosomal restriction fragment patterns by pulsed-field gel electrophoresis. Infect Control Hosp Epidemiol 1993; 14:595-600.
53. Kersulyte D, Struelens MJ, Deplano A, Berg DE. Comparison of arbitrarily-primed PCR and macrorestriction (pulsed-field gel electrophoresis) typing of Pseudomonas aeruginosa strains from cystic fibrosis patients. J Clin Microbiol 1995; 33:2216-9.
54. Georghiou PR, Hamill RJ, Wright CE, et al. Molecular epidemiology of infections due to Enterobacter aerogenes: identification of hospital outbreak-associated strains by molecular techniques. Clin Infect Dis 1995; 20:84-94.
55. Reboli AC, Houton ED, Monteforte JS, Wood CA, Hamill RJ. Discrimination of epidemic and sporadic isolates of Acinetobacter baumannii by repetitive element PCR-mediated DNA fingerprinting. J Clin Microbiol 1994; 32:2635-40.
56. Woods CR, Versalovic J, Koeuth T, Lupski JR. Analysis of relationships among isolates of Citrobacter diversus by using DNA fingerprints generated by repetitive sequence-based primers in the polymerase chain reaction. J Clin Microbiol 1992; 30:2921-9.
57. Struelens MJ, Carlier E, Maes N, Serruys E, Quint WGV, van Belkum A. Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fmgerprinting. J Hosp Infect 1993; 25:15-32.
58. Vernet V, Madoulet C, Chippaux C, Philippon A. Incidence of two virulence factors (aerobactin and mucoid phenotype) among 190 clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases. FEMS Microbiol Lett 1992; 96:1-6.
59. Darfeuille-Michaud A, Jallat C, Aubel D, et al. R-Plasmid-encoded adhesin factor in strains responsible for human nosocomial infections. Infect Immun 1992; 60:44-55.
60. Di Martino P, Livrelli V, Sirot D, Joly B, Darfeuille-Michaud A. A new fimbrial antigen harbored by CAZ-5/SHV-4-producing Klebsiella pneumoniae strains involved in nosocomial infections. Infect Immun 1996; 64:2266-73.